Sivia Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Hold
16,440
0.26% 81
2026
Q1
$1.98M Sell
16,440
-6,553
-28% -$757K 0.38% 51
2025
Q4
$2.42M Buy
22,993
+6,669
+41% +$626K 0.49% 26
2025
Q3
$1.37M Buy
16,324
+4,830
+42% +$398K 0.39% 34
2025
Q2
$910K Buy
11,494
+3,941
+52% +$313K 0.31% 48
2025
Q1
$678K Buy
7,553
+624
+9% +$58.3K 0.32% 41
2024
Q4
$689K Buy
6,929
+178
+3% +$18.4K 0.34% 36
2024
Q3
$767K Buy
6,751
+267
+4% +$31.7K 0.45% 35
2024
Q2
$803K Sell
6,484
-614
-9% -$79.1K 0.54% 28
2024
Q1
$937K Sell
7,098
-10
-0.1% -$1.23K 0.64% 27
2023
Q4
$775K Buy
+7,108
New +$738K 0.59% 27

Other funds holding MRK

Sivia Capital Partners's MRK Position: Q2 2026 in Review

Sivia Capital Partners held its Merck (MRK) position steady in Q2 2026 at 16,440 shares worth $2.11M. The position accounts for 0.26% of the portfolio, ranked #81.

Sivia Capital Partners first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.42M in Q4 2025. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Sivia Capital Partners held 16,440 shares of Merck worth $2.11M as of Q2 2026.
  • Sivia Capital Partners left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.26% of Sivia Capital Partners's portfolio in Q2 2026, its #81 holding.
  • Sivia Capital Partners first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Sivia Capital Partners's Merck position peaked at $2.42M in Q4 2025.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.